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MMR and fever/seizures 
 Rowhani-Rahbar A, Fireman MA, et 
al. Effect of Age on the Risk of Fever 
and Seizures Following Immunization 
with Measles-Containing Vaccines in 
Children.  JAMA Pediatrics. 2013, 
October 13, E1-7.  
 840,348 kids 12-23 mos received 
MMR or MMR-V vaccine between 
2001-2011 in VSD clinics.     
MMR and Fever, seizures 
 Increased risk of seizures in 7-10 day high 
risk interval for kids who received the 
vaccine at 16-23 (vs 12-15) mos of age.  
• RR 6.5 (95% CI 5.3-8.1) vs RR 3.4 (95%CI 3-
3.9) 
• Attributable risk 9.5 vs 4 cases per 10,000 
doses 
 Increased risk of fever and seizures in kids 
receiving MMR-V vs MMR +/- separate 
Varicella vaccine 
• 1.4-fold increase in fever 
• 2-fold increase in seizures 
Why?  
 Kids have higher immune 
responsiveness in 16-18 month age 
range 
• Peak incidence of febrile seizures 
 
So what? 
 Stick to recommended childhood 
vaccine schedule. 
 Discuss additional risk when parents 
want to follow alternate schedules. 
 Don’t use MMR-V combination 
vaccine. 
How do we manage 
blood pressure in 
ischemic stroke? 
 
He J et al. Effects of immediate blood pressure 
reduction on death and major disability in 
patients with acute ischemic stroke: The CATIS 
randomized clinical trial. JAMA 2013 Nov 17; [e-
pub ahead of print].  
 
 Randomized 4700 Chinese to 
antihypertensive therapy (140/80) goal or 
no antihypertensive.   
 Initiated with 24 hours of presentation 
(but stroke could be 48 hours before) 
 Excluded if BP >= 220/120, thrombolytic, 
a reason to lower BP (CHF) 
 Average BP at entry 167/97 
 Used ACE, Calcium channel blocker 
and diuretics 
 Goal: 10-25% within 24 hours 
 At 24 hours 
• Systolic decreased by 22mmHg 
treatment group 
• Systolic decreased by 13mm Hg control 
group  
 Outcome of death or disability:  
For both groups… 
 Death or disability same at 14 days: 
odds ratio, 1.00 [95%CI, 0.88 to 
1.14]; P = .98) 
 Death or disability same at 3 
months: odds ratio, 0.99 [95%CI, 
0.86 to 1.15]; P = .93) 
 Death the same….so not just driven 
by disability. 
 220/120 unless evidence of end 
organ problems 
 Reduce by only 15% in 24hrs. 
 You can reduce the BP and not make 
them worse.   
 But, go have a coffee instead. 
 
 
Special Case 
 If thrombolytic candidate: 
• <185/110 
 Recommendation: 
• Labetalol IV 
• Nicardipine infusion 
How about in 
hemorrhagic stroke? 
Blood Pressure Control 
Craig S. Anderson and the 
INTERACT2 investigators. Rapid 
Blood-Pressure Lowering in 
Patients with Acute Intracerebral 
Hemorrhage. N Engl J Med 2013; 
368:2355-2365. 
Study 
 Acute, spontaneous, bleeds 
 Randomized within 6 hours to 
SBP<140mmHg 
 Or conventional (<180mm hg). 
 2794 patients, 90 day outcomes 
 No difference in outcomes and no 
change in size of hematoma!! 
 
 
 
Wait a minute.  Didn’t they 
conclude there was reduced 
morbidity and an improved 
Rankin score? 
Here is the table from NEJM.. 
Here is the table from the “supplementary 
material”…hmm why are there two more columns? 
What the heck? 
Blood transfusions in GI 
bleeders 
Villanueva C et al. Transfusion 
Strategies for Acute Upper 
Gastrointestinal Bleeding. N Engl J Med 
2013;368:11. 
 
 
 Study of 898 patients with GI 
bleeding admitted to hospital 
 Randomized to restrictive-strategy vs 
liberal-strategy 
 Exclusions: most commonly for “low 
risk of rebleeding”. Also excluded 
“exsanguinous bleeding”. 
 Included: all types of upper GI bleed, 
but predominantly ulcer and variceal 
 Deviations from protocol occurred in 
< 10% of patients 
 Restrictive: 
• Transfuse at Hgb < 7 g/dl 
• Target Hgb 7 – 9 g/dl 
 Liberal: 
• Transfuse at Hgb < 9 g/dl 
• Target Hgb 9 – 11 g/dl 
 
 Restrictive group: 
• 51% received NO transfusion 
• Mean units transfused – 1.5 
 Liberal group: 
• 14% received NO transfusion 
• Mean units transfused – 3.8 
 Hemoglobin concentrations at 45 
days were about the same. 
Bottom line 
 Lower mortality at 45 days post-
hospitalization in the restrictive 
group 
 A restrictive transfusion strategy in 
patients with acute upper GI 
bleeding is safe and effective 
compared to a liberal transfusion 
strategy 
• Consistent with studies of critically ill 
patients (non-GI bleeds)  
 
Enhancing the Benefits of Fruit Intake 
 Primary prevention 
• Type 2 DM 
• Stroke 
• Heart disease 
• Cancers 
 Greater variety, rather than quantity 
may be more important 
 
Muraki I et al. BMJ 2013; 347 
Fruit intake and DM2  
 Data from  
• Nurses Health Study I, II (121,700; 
116,671) 
• Health Professional Follow-up Study 
(51,529) 
• Excluded  
 Preexisting diabetics, heart disease, cancer 
 Missing data for fruits or fruit juice 
• Food frequency questionnaires, diet records 
• Specific fruits  
• Fruit juices 
Muraki I et al. BMJ 2013; 347 
Fruit intake and DM2  
 Total whole fruit intake weak 
reduction in risk 
• HR 0.98  (0.96-0.99) for every 3 
servings/week 
 Fruit juice consumption associated 
with increased risk 
 Results were not dependent on 
glycemic index of fruits 
Fruit intake and DM2  
 Whole fruit intake and risk of DM  
 Linear trend estimated based on 3 serving/week 
increment Hazard Ratio (95% CI) 
Total whole fruits 0.98 (0.96-0.99) 
Blueberries 0.74 (0.66-0.83) 
Grapes/raisins 0.88 (0.83-0.93) 
Apples/pears 0.93 (0.90-0.96) 
Bananas 0.95 (0.91-0.98) 
Grapefruit 0.95 (0.91-0.99) 
Oranges 0.99 (0.95-1.03) 
Peaches/plums/apricot
s 
0.97 (0.92-1.02) 
Prunes 0.89 (0.79-1.01) 
Strawberries 1.03 (0.96-1.10) 
Cantaloupe 1.10 (1.02-1.18) 
Fruit intake and DM2  
• Replacing 3 servings/wk juice with whole fruit 
If life gives you lemons, 
Do whatever you like. 
 
But, if life gives you apples, don’t 
make apple juice; just eat them. 
 
…or, better yet, trade them for 
blueberries. 
And yet more BP…. 
Worth the Download: ACOG Task Force on 
Hypertension in Pregnancy.Hypertension in 
pregnancy: Report of the American College of 
Obstetricians and Gynecologists' Task Force on 
Hypertension in Pregnancy. Obstet Gynecol 
2013 Nov; 122:1122. 
(http://dx.doi.org/10.1097/01.AOG.000043738
2.03963.88) 
 
Proteinuria no longer required for pre-
eclampsia if other findings  
 Instead can have:  
• thrombocytopenia,  
• impaired liver function,  
• new-onset renal insufficiency, 
• pulmonary edema, 
• new development of cerebral or visual 
disturbances 
 
 
Other stuff… 
 Treat only if BP >160/110 (!!) 
• If sx (hypertensive emergency) treat at 
lower BP 
• Lowering BP may effect fetal perfusion 
• Lowering BP does not change the course 
of preeclampsia. 
 
Chronic HTN 
 Treat chronic HTN in pregnancy if BP 
160/105 with goal < 160/105 and > 
120/80 
 
 
 But…..treat early to avoid hypospadias: 
OB & GYN, 2014;123:309 (some problems 
with study….like they didn’t define HTN!!) 
Magnesium 
intrapartum/postpartum  
 Only for patients with severe pre-
eclampsia including: 
• SBP>160mmHg,  
• low platelets,  
• impaired liver function,  
• AKI, pulmonary edema 
• CNS changes 
 No bedrest for preeclampsia 
New Recommendation from USPSTF 
 Humphrey L et al. Screening for lung 
cancer with low-dose computed 
tomography: A systematic review to 
update the U.S Preventive Services 
Task Force Recommendation. Ann 
Intern Med 2013;159(6):411-420. 
USPSTF recommends annual screening 
for lung cancer with low-dose computed 
tomography in adults ages 55 to 80 years 
who have a 30 pack-year smoking 
history and currently smoke or have quit 
within the past 15 years. Screening 
should be discontinued once a person 
has not smoked for 15 years or develops 
a health problem that substantially limits 
life expectancy or the ability or 
willingness to have curative lung 
surgery.  
 
Grade: B recommendation. December 2013. 
Why screen? 
 Lung cancer is the leading cause of 
cancer deaths in the U.S. – 27% of 
cancer deaths 
 75% of patients with lung cancer 
present with symptoms due to 
incurable or advanced local or 
metastatic disease 
 Early stage lung cancer is potentially 
curable 
 


NLST 
 6.5 year follow up 
 3 annual low-dose CT scans 
 Compared to annual CXR 
 Showed: 
• 20% RRR in lung cancer specific mortality 
• Absolute risk of lung cancer death: 
 Screened group: 1.3% 
 Control group: 1.6% 
• Reduction in overall mortality of 6.7% 
(2000 deaths vs 1877)  
NNT 
 Number needed to treat (or screen) 
 
 NNS = 1/ARR 
 ARR = 1.6 – 1.3 = 0.3% 
 NNS = 1/0.003 = 333 
 
 So, to avert 1 lung cancer death, 333 
would need to be screened using the 
NLST method.  
Risks? 
 The number needed to harm for 
“abnormal finding” is only 4 
• More testing 
• More biopsies 
• More surgeries 
• More anxiety 
What should we do?  
 This dilemma will arise multiple 
times per day in my clinic! 
Limiting Screen Time 
 <2 hour AAP guideline is over 10 
years old 
 Outcomes 
• Obesity 
• Poor sleep 
• Inactivity 
• Academic underachievement 
 
Do as I say, not as I do… 
 1550 parents, nationally represented sample 
• Parents’ daily TVV= 4.07 hrs 
• TV’s in home= 3 
• TV’s in parent bedroom= 70% 
• TV’s in child bedroom= 46% (increased w age) 
• Parent restricted TVV= 2.67 (1 never, 4 often) 
 Parent TVV strongest association with child TVV 
across all ages 
• Each hour corresponds with add’l 23 min child TVV 
 Parents underestimated adolescents TVV by 47 
min 
Bleakley, A et al.   Pediatrics July 2013  
What can we do?  
 Factors known to increase screen 
time 
• Enforce parental restrictions 
• Limit coviewing with parents 
• No TV in bedroom 
• Limit number of TVs in home 
• Don’t eat meals in front of TV 
 
• And, of course, role model desired 
behaviors… 
 
Does cognitive rest 
improve post-concussion 
syndrome? 
Brown NJ et al. Effect of cognitive activity level 
on duration of post-concussion symptoms. 
Pediatrics 2013 Jan 6; [e-pub ahead of print]. 
http://pediatrics.aappublications.org/content/ea
rly/2014/01/01/peds.2013-2125.abstract)  
 
 Prospective cohort at concussion 
clinic at Boston Children’s Hospital 
(spectrum bias??) 
 Within 3 weeks of injury 
 Used a validated “Post Concussion 
Symptom Scale” 
 1124 screened: 335 included age 8 to 23 
years 
• Mean age 15 
 All had sports related concussion  
 62% were male 
 19% reported a loss of consciousness 
 37% reported experiencing amnesia 
 Rated their cognitive activity on scale 
of 0-4 at each visit. 
 Cognitive activity included reading, 
homework, video games, etc. 
 Non-cognitive activity included TV 
(yup!), movies or music. 

 Mean duration of sx: 43 days 
 Only associations with recovery 
were: 
• Initial symptom score 
• Cognitive activity 
 But……. 
 

Initial Score: 95% CI 0.9738-0.9856 
Cognitive activity: 95% CI 0.9924-0.9960 
When you have to carry your CI out to  
4 decimal points there is not much of an association 
Round them off to 2 decimal points and they lose! 
Maybe there is something else not being measured? 
Other stuff 
 Not randomized but you would expect the people 
with more sx to do less activity just ‘cos 
 Those with more sx had more activity 
 So likely not biased.  
 See also NIM: Sports related concussion available 
at: 
http://books.nap.edu/download.php?record_id=1
8377 
 (see next two slides for guidelines…I will not 
review these slides) 
Another J-curve? 
 Depression historically linked to alcohol intake 
 PREDIMED study- prospective cohort  
• 5505 adults 55-80 yo without depression or CAGE 
+ 
• Annual food freq questionnaire over 7 years 
• Depression= clinical diagnosis or antidepressant 
drugs 
 Moderate intake (5-15 g/day) associated with 
lower risk of incident depression 
• HR 0.72, 95% CI (0.53-0.98) 
 Wine intake (2-7 glasses per week) 
• HR 0.68, 95% CI (0.47-0.98) 
Gea A et al.  BMC Medicine 2013, 
11:192 
Always caveats… 
 Heavier drinkers at higher risk 
 Not consistent results between 
studies 
• Excluding problem drinkers could 
explain 
 Other confounding lifestyle factors  
 
Dentists and Doctors 
disagree… 
Should parents suck on pacifiers to 
“clean” them?  
 Dentists say “NO!” 
  
 …but are there some benefits?   
Parents sucking pacifiers 
 184 infant birth cohort (Sweden) 
• At least one parent with allergies 
• 4 month salivary microbiota 
• 6 month parental survey about pacifier 
practices 
• 18, 36 month allergy assessment 
• Respiratory infections in first 6 mos  
• Relationship to mode of delivery 
 
 
 
Parents sucking pacifiers 
 36% of parents suck on pacifiers to 
clean them 
• Salivary microbiota differed 
• No difference in respiratory infections in first 6 
mos 
• Reduced allergic disease at 18 mos -Odds 
Ratios (95% CI) 
 
 
 
Hesselmar B et al. Pediatrics 2013; 131: 1-9.  
18 months 36 months 
Asthma 0.12  (0.01-0.99)  Hazard Ratio 0.51 
(p=0.04) 
Eczema 0.37 (0.15-0.91) 
Sensitization 0.37 (0.10-1.27) 
TB screening 
 What happens when you apply a highly 
sensitive test to a population with low 
disease prevalence?  
TB Screening 
 Slater ML et al. Challenges with 
QuantiFERON-TB Gold Assay for 
Large-Scale, Routine Screening of 
U.S. Healthcare Workers. Am J 
Respir Crit Care Med 
2013;188(8):1005.  
 
TB Screening 
 Single-center study at Stanford 
University Medical Center 
 Retrospectively evaluated the 
application of QuantiFERON-TB Gold In-
Tube (QFT) for screening ~ 10,000 
health-care workers annually for TB, 
and compared to historical control 
 Used the manufacturer recommended 
cut-off (>/=0.35IU/mL) 
 

So… 
 In the initial testing, 13.4% of HCW’s 
had a positive test! 
 For those testing negative initially, 
the conversion rate was 4.4%. 
 Historically, at Stanford, the 
conversion rate was 0.4%. 
What’s going on here? 
 Overall TB rates in the area of the study 
were low: 
• Incidence of TB at Stanford Med averages 14 
cases 
• Incidence of TB in Santa Clara County during 
the period was 10.8/100,000 persons 
 Incidence of TB in the U.S. is in decline 
 There is no gold standard to detect latent 
TB 
 A positive test result alone is not enough to 
diagnose latent TB—consider history and 
epidemiology 
How about “Low-T” 
Is treatment safe? 
Vigen R et al. Association of testosterone therapy 
with mortality, myocardial infarction, and stroke in 
men with low testosterone levels. JAMA 2013 Nov 6; 
310:1829. 
(http://dx.doi.org/10.1001/jama.2013.280386) 
Cappola AR.Testosterone therapy and risk of 
cardiovascular disease in men. JAMA 2013 Nov 6; 
310:1805. 
(http://dx.doi.org/10.1001/jama.2013.280387) 
 
NPR and CBS beat me 
to this one.  So…. 
Well what about my erections, 
doc? 
 140 men (age 40-70) with erectile 
dysfunction. 
 Testosterone low <330ng/dl or free 
testosterone of <50pg/ml 
 
 
 Spitzer M et al. Effect of testosterone replacement on 
response to sildenafil citrate in men with erectile 
dysfunction: A parallel, randomized trial. Ann Intern Med 
2102 Nov 20; 157:681.  
Run in phase… 
 Optimized sildenafil dose (don’t ask) 
 Then….randomized to either placebo 
or testosterone 
 Testosterone 649ng/dl v. 347ng/dl 
 Erectile Dysfunction  Domain of the  
International Index of Erectile 
dysfunction (which I did not know 
existed!) 
 
Exclusion 
 Prostate or breast cancer 
 Structural abnormalities 
 Major psychiatric disease 
 Elevated creatinine 
 HbA1c>8.5% 
 MI or stroke <6months 
 BP >160/100 
 Good power to find a difference 
What did they find? 
 Sildenafil: EFD score (mean, 7.7 
[95% CI, 6.5 to 8.8]) increase 
 Testosterone: 2.2 [CI, -0.8 to 5.1]; 
P= 0.150). (same in both groups) 

To D or not to D… 
The age-old question 
 Meta-analysis for D (without calcium) 
in adults 
• 23 studies, 4032 participants, 92% 
female 
• BMD measured at 1-5 sites 
• 10 studies with <800 IU per day 
 
 
Vitamin D supplements and bone density 
 Vit D levels increased from 53-92 nmol/L 
 No difference at 
• Spine  
• Total hip 
• Trochanter 
• Total body 
• Forearm 
 Small benefit at femoral neck (0.8%, 
95%CI 0.2-1.4%)-heterogeneous data 
 Evidence of bias toward positive results 
 
 Reid IR et al.  Lancet 2013 
Soooo,  what do we do? 
 Don’t 
• Vitamin D appears to confer little added 
benefit over calcium supplements alone 
in patients who are not deficient and 
high-risk. 
 IOM recommendation 
• 40 nmol/L is adequate concentration 
Which NSAID is safest? 
 Bhala, N et al. Vascular and upper 
gastrointestinal effects of non-
steroidal anti-inflammatory drugs: 
meta-analyses of individual 
participant data from randomised 
trials. Lancet 2013;382(9894):769 -
779. 
 
The article 
 Meta-analysis 
• 280 trials of NSAID vs placebo 
• 474 trials of NSAID vs NSAID 
• Over 350,000 participants 
• Over 230,000 person-years 
 Outcomes 
• Major vascular event (non-fatal MI, non-fatal stroke, 
vascular death) 
• Major coronary event (non-fatal MI, coronary death) 
• Stroke 
• Mortality 
• Heart failure 
• Upper GI complications (perforation, obstruction, bleed) 
 
 For major vascular 
events: 
• Coxibs RR 1.37 
• Diclofenac RR 
1.41 
 For vascular death: 
• Coxibs RR 1.58 
• Diclofenac 1.65 
 HF ~ risk doubled 
for all NSAIDs 
 For upper GI 
complications: 
• Coxibs RR 1.81 
• Diclofenac RR 1.89 
• IBU RR 3.97 
• Naproxen RR 4.22 
Bottom line 
 For patients at risk for vascular 
disease, naproxen appears safest 
 For patients at risk for upper GI 
complications, coxibs appear safest 
 Anybody know patients at risk for 
vascular disease and upper GI 
complications?  
…yeah, we don’t either! 
•But seriously, there’s still acetaminophen 
Does time to suturing 
change infection rate? 
Quinn JV et al. Traumatic lacerations: 
What are the risks for infection and has 
the ‘golden period' of laceration care 
disappeared? Emerg Med J 2014 Feb; 
31:96. 
(http://dx.doi.org/10.1136/emermed-
2012-202143) 
-  
 3957 of whom 2663 had complete 
follow-up data.  
• Maybe the rest died of sepsis?? 
 Lacerations NOT caused by bites. 
 Consecutive patients 
 Followed up at 30 days to determine 
infection rate. 
 Infection defined as need to visit a 
health practitioner and treated with 
ABX (one weakness here). 
 
 2.6% overall infection rate 
 Multivariate analysis showed 
infection rate increased by: 
• Diabetes OR 3.1  
• Length of wound >5cm OR 2.4  
• Wound contamination OR 1.9  
 Time didn’t seem to make a 
difference (<12h or >12h)…some 
wounds left open, though. 
 
 
 
 
All estrogens are not created 
equal 
 Two studies looking at risk of venous 
thrombosis with different hormonal 
therapies 
• Smith NL et al.  Lower Risk of 
Cardiovascular Events in Postmenopausal 
Women Taking Oral Estradiol Compared 
With Oral Conjugated Equine Estrogens.  
JAMA 2013 
• Stegeman BH et al. Different combined oral 
contraceptives and the risk of venous 
thrombosis: systematic review and network 
meta-analysis.  BMJ 2013; 347:f5298. 
Postmenopausal HRT: CEE vs 
Estradiol 
 Smith, et al.   
• Case-control study of 384 
postmenopausal women on HRT 
 68 VT  (primary outcome) 
 67 MI 
 48 Ischemic stroke 
• Group Health Cooperative 
 Preferred drug used by 87% 
• CEE until Jan 1, 2003-Jan 31, 2005 
• Estradiol in Feb 1, 2005-Dec 31, 2009 
Postmenopausal HRT: CEE vs 
Estradiol 
 Venous Thrombosis risk greater in CEE-users 
• OR 2.08 (1.02-4.27) p=0.045 
 MI risk greater  
• OR 1.87 (0.91-3.84) p=0.09 
 Ischemic stroke risk not significantly different 
 Biologic plausibility: 
• nAPCsr median levels were higher in the CEE group 
than in the estradiol group 
 Not randomized assignment, but systemwide 
recommendations (eliminates some bias?) 
Combination OCPs and VT risk 
 
 
 
 
 
 
 
 
Non-use First Second Third  
Non-use 1 -- -- -- 
First 
generation 
(lynestrenol, 
norethisterone) 
3.2 (2.0-5.1) 1 -- -- 
Second 
generation 
(norgestrel, 
levonorgestrel) 
2.8 (2.0-4.1) 0.9 (0.6-
1.4) 
1 -- 
Third 
generation 
(gestodene, 
desogestrel, 
norgestimate) 
3.8 (2.7-5.4) 1.2 (0.8-
1.9) 
1.3 (1.0-
1.8) 
1 
Other  
(drospirenone, 
Cyproterone 
acetate) 
0.9 
Dose dependent effects occurred with gestodene, desogestrel, 
levonorgestrel  
Combination OCPs and VT risk 
 Baseline VT risk 1.9-3.7 per 10,000 
py 
 ALL combination OCP’s increased VT 
risk 
 RR 3.5 (2.9-4.3) 
 Higher doses of EE related to 
increased risk 
• Depends on progestin (desogestrel, but 
not levonorgestrel) 
 
Recommendations 
 Although more studies are needed 
for postmenopausal HRT,  
• Consider using estradiol instead of CEE 
in women who take HRT for symptoms 
• Consider using OCP containing 30 mcg 
EE and levonorgestrel as first line 
All that dwindles is not Alzheimer’s… 
 Boyle PA et al. Much of late life cognitive 
decline is not due to common 
neurodegenerative pathologies. Ann 
Neurol 2013;74(3):478. 
The study 
 Subjects recruited for longitudinal 
studies, with no dx of dementia 
(Rush Memory and Aging Project and 
Religious Orders Study) 
 850 subjects 
 Annual cognitive assessments for 
average of 75 years (range 2-18) 
 Autopsy with brain pathological exam  
The study 
 Calculated the rate of change of 
cognitive decline (2nd order 
derivative—ouch, is that calculus?) 
 Also determined the range of 
variability accounted for by 
pathologic differences between 
subjects 
 
No surprise here… 
But… 
Bottom line 
 In the majority of subjects (59%), 
the variability in cognitive decline 
could not be predicted by the 
pathologic burden of dementing 
diseases (Alzheimers, vascular 
events, Lewy bodies) 
 So…we don’t really understand 
dementia.  
PCOS treatment 
 Randomized trial: 198 women with PCOS 
• 56 Metformin alone (M) 1000 mg / day 
• 51 Spironolactone alone (S) 50 mg/day 
• 62 Metformin+spironolactone (M+S) 
 Outcomes of interest at 0,3,6 mos 
• BMI 
• Total T 
• Glucose and insulin sensitivity 
• LH, FSH 
• Menstrual cycle pattern 
• Waist-hip ratio (WHR) 
• BP 
• Ferriman-Gallwey Score (FG score) 
 
Ganie MA et al. J Clin Endocrinol Metab 
2013:  
PCOS treatment 
 All groups 
• No significant change in weight, BMI, 
WHR, BP 
• Increased menstrual cycles per year 
• Improved FG score 
• Decreased Total T  
• Improved insulin sensitivity 
 
PCOS treatment 
 Combination ( M+S) group 
• No increase in adverse events 
• Better compliance 
• Decreased FG score, total T, LH, FSH, 
glucose and insulin 
 
PCOS treatment 
Metformin Spironolactone M+S 
Menstrual 
cycles/yr 
10.02  (5.95) 10.35 (6.45) 10.86 (6.13) b,y 
FG score 9.67 (13.27) 9.56 (13.65) 9.09 (13.11) b,y,z 
Total serum T 1.89 (3.03) 1.80 (2.98) 1.58 (3.10) b,y,z 
AUC glucose  14841.0 
(15671.6) 
14720.0 
(15960.0) 
14400.5 
(15665.8)b,z 
AUC insulin 5034.91 
(6466.81) 
5396.60 
(6568.14) 
4051.46 
(6497.81)b,y,z 
• Outcomes (mean, baseline) at 6 mos 
b= 0 vs 6 month 
y= M vs M+S 
z=S vs M+S 
Quick Pearls 
Quick pearls 
 5 days of prednisone is fine for COPD 
as well as for asthma. 
 
 
 ACE + ARB does not help anyone 
 
 Analysis at: 
http://www.jwatch.org/na33100/2013/12/31/dual-
blockade-renin-angiotensin-aldosterone-system-doesnt 
 
 Renal stenting does not work for  
atherosclerotic renal artery disease 
as a treatment for hypertension. 
 
 PPIs can lead to Vit B-12 deficiency 
(as can metformin). 
 
 
 
 
References for quick pearls 
 Cooper CJ et al. Stenting and medical therapy for atherosclerotic 
renal-artery stenosis. N Engl J Med 2013 Nov 18; [e-pub ahead of 
print]. (http://dx.doi.org/10.1056/NEJMoa1310753) 
 
 Bittl JA.Treatment of atherosclerotic renovascular disease. N Engl 
J Med 2013 Nov 18; [e-pub ahead of print]. 
(http://dx.doi.org/10.1056/NEJMe1313423) 
 
 Leuppi JD et al. Short-term vs conventional glucocorticoid therapy 
in acute exacerbations of chronic obstructive pulmonary disease: 
The REDUCE randomized clinical trial. JAMA 2013 Jun 5; 
309:2223. (http://dx.doi.org/10.1001/jama.2013.5023)  
 
 Lam JR et al. Proton pump inhibitor and histamine 2 receptor 
antagonist use and vitamin B12 deficiency. JAMA 2013 Dec 11; 
310:2435. (http://dx.doi.org/10.1001/jama.2013.280490) 
 
Dogma overturned? 
 Amin FM et al. Magnetic resonance 
angiography of intracranial and 
extracranial arteries in patients with 
spontaneous migraine without aura: A 
cross-sectional study. Lancet Neurol 
2013;12:425. 
 
 Showed that migraine patients do not 
display any demonstrable vascular 
changes while having their headaches.  
The fungus amongus 
Amichai B et al. The effect of domestic 
laundry processes on fungal contamination 
of socks. Internat J Derm 
2013;52(11):1392. 
 
The short version: washing socks in 40 
degree C water eliminates most fungi; using 
60 degree C water kills all of the usual 
pathogens. 
Are beta blockers safe in 
those with COPD? 
Quint JK et al. Effect of β blockers on mortality 
after myocardial infarction in adults with COPD: 
Population based cohort study of UK electronic 
healthcare records. BMJ 2013 Nov 22; 
347:f6650. 
(http://dx.doi.org/10.1136/bmj.f6650) 
 
 1069 patients with COPD and 
myocardial infarction.  
 Study was retrospective. 
 23% on beta blockers at baseline 
 22% received beta blockers around 
their MI. 
 55% did not get any beta blockers 
 Observed for 2.9 years. 
 Adjusted the best they could for 
confounders. 
 Hazard ratio for death: 0.6 for those 
on beta-blockers at study start. 
 Hazard ratio: 0.5 for those who 
started beta blockers as inpatient. 
 So, beta-blockers are safe in COPD 
and inhalers are safe in the setting of 
MI  
 Not first study to find this. 
 In community patients beta-blockers 
were safe in those with severe COPD. 
 Actually better survival 
 Mechanism:?  Likely decrease in 
adrenergic response. 
 See also: 
  BMJ 2011 May 10; 342:d2549. (http://dx.doi.org/10.1136/bmj.d2549) 
 Rutten FH et al. β-blockers may reduce mortality and risk of exacerbations 
in patients with chronic obstructive pulmonary disease. Arch Intern Med 
2010 May 24; 170:880.  
 
